Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial
Thank you for registering! Take a moment to confirm your subscription to Insider Trades Newsletter so that you can access MarketBeat's tools, reports, and news. Please click the "Send Confirmation Email" button and we'll send you an email with confirmation instructions.
Send Confirmation Email
NASDAQ:PETV

PetVivo (PETV) Stock Price, News & Analysis

→ **Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! (From Huge Alerts) (Ad)
Free PETV Stock Alerts
$0.74
-0.04 (-4.91%)
(As of 11:40 AM ET)
Compare
Today's Range
$0.61
▼
$0.86
50-Day Range
$0.54
▼
$1.09
52-Week Range
$0.33
▼
$2.90
Volume
7,844 shs
Average Volume
48,911 shs
Market Capitalization
$12.49 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media
PETV stock logo

About PetVivo Stock (NASDAQ:PETV)

PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.

PETV Stock Price History

PETV Stock News Headlines

April 24, 2024 | investing.com
Petvivo enacts cost cuts, executives take salary reductions
April 19, 2024 | investing.com
PetVivo Holdings CEO acquires $90k in company stock
April 8, 2024 | globenewswire.com
PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE IVAPM PAIN MANAGEMENT FORUM IN INDIANAPOLIS, INDIANA
April 3, 2024 | globenewswire.com
PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE ACVSMR SYMPOSIUM IN NAPLES FLORIDA
March 15, 2024 | fortune.com
AT&T’s CFO on how the company saved $6 billion—and is planning to scrimp another $2 billion by 2026
March 14, 2024 | globenewswire.com
SmallCapVoice.com Inc. (“SCV”) to Host First Annual Safety Summit featuring Up-and-Coming Public Companies
March 11, 2024 | msn.com
PetVivo terminates ATM sales agreement with ThinkEquity
March 11, 2024 | markets.businessinsider.com
PetVivo Holdings Names Garry Lowenthal CFO
March 11, 2024 | globenewswire.com
Garry Lowenthal Joins PetVivo Holdings, Inc. as the Chief Financial Officer
March 8, 2024 | finance.yahoo.com
New to The Street Announces its Five Corporate TV Interviews, Airing Episode 561 on the FOX Business Network Monday, March 11, 2024, at 10:30 PM PT
March 5, 2024 | finance.yahoo.com
PetVivo Holdings, Inc. Commences Trading on Upstream Under PETV
February 29, 2024 | globenewswire.com
Clinical Study Results Involving Spryng, a PetVivo Holdings, Inc. Product, Presented at the Veterinary Orthopedic Society Annual Conference in Lake Tahoe, California
February 27, 2024 | finance.yahoo.com
PetVivo Holdings, Inc. Approved to Dual List on Upstream
February 15, 2024 | investing.com
PetVivo reports revenue growth and net loss reduction in Q3
February 14, 2024 | finance.yahoo.com
PetVivo Holdings Third Quarter 2024 Earnings: US$0.12 loss per share (vs US$0.23 loss in 3Q 2023)
February 13, 2024 | finance.yahoo.com
PetVivo Holdings, Inc. (NASDAQ:PETV) Q3 2024 Earnings Call Transcript
February 13, 2024 | finanznachrichten.de
PetVivo Holdings, Inc.: PetVivo Reports Third Quarter of Fiscal 2024 Financial Results
February 12, 2024 | finance.yahoo.com
PetVivo Reports Third Quarter of Fiscal 2024 Financial Results
February 10, 2024 | msn.com
PetVivo Holdings Initiates New Financial Obligation
February 8, 2024 | msn.com
PetVivo Holdings Strikes Key Investment Agreements
February 7, 2024 | finance.yahoo.com
PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE THIRD QUARTER ENDED DECEMBER 31, 2024
February 7, 2024 | finance.yahoo.com
PetVivo Holdings, Inc. Announces Release of Clinical Study Results Involving Feline Tolerance to Intra-articular Injections of Spryng™ with OsteoCushion™ Technolgoy
January 31, 2024 | finance.yahoo.com
PetVivo Holdings, Inc. Announces Release of Clinical Study Results Involving Canine Tolerance to Intra-articular Injections of Spryng™ with OsteoCushion™ Technology
January 23, 2024 | markets.businessinsider.com
PetVivo Gets Notice Of Allowance For Key Patent Application
January 23, 2024 | finanznachrichten.de
PetVivo Holdings, Inc.: PetVivo Recieves Notice of Allowance from United States Patent and Trademark Office for Key Patent Application
See More Headlines

Company Calendar

Last Earnings
6/29/2023
Today
5/20/2024
Next Earnings (Estimated)
7/04/2024
Fiscal Year End
3/31/2025
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:PETV
CUSIP
N/A
CIK
1512922
Web
www.petvivo.com
Phone
952-405-6216
Fax
N/A
Employees
25
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($0.86)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-8,720,000.00
Net Margins
-1,016.64%
Pretax Margin
-1,016.64%
Return on Equity
-1,319.59%
Return on Assets
-299.92%

Debt

Debt-to-Equity Ratio
0.02
Current Ratio
0.90
Quick Ratio
0.62

Sales & Book Value

Annual Sales
$1.05 million
Price / Sales
12.56
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.07 per share
Price / Book
11.19

Miscellaneous

Outstanding Shares
16,770,000
Free Float
13,399,000
Market Cap
$13.14 million
Optionable
Not Optionable
Beta
2.15

Key Executives

  • Mr. John Lai (Age 62)
    CEO, President & Director
    Comp: $312.65k
  • Mr. Randall A. Meyer (Age 60)
    Chief Operating Officer
    Comp: $245.41k
  • Mr. Garry N. Lowenthal (Age 65)
    Chief Financial Officer
  • Mr. Randy Wenthold
    Chief Science Officer
  • Mr. John F. Dolan (Age 59)
    General Counsel, Chief Business Development Officer & Secretary
    Comp: $40.25k
  • Mr. Gary DeMel (Age 67)
    Executive Vice President of Business Development
  • Mr. Russell Siakel
    Director of Marketing

Key Competitors

View All Competitors

Insiders

View All Insider Transactions

PETV Stock Analysis - Frequently Asked Questions

How have PETV shares performed in 2024?

PetVivo's stock was trading at $1.06 at the start of the year. Since then, PETV shares have decreased by 29.7% and is now trading at $0.7450.
View the best growth stocks for 2024 here.

When is PetVivo's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, July 4th 2024.
View our PETV earnings forecast.

How were PetVivo's earnings last quarter?

PetVivo Holdings, Inc. (NASDAQ:PETV) announced its earnings results on Thursday, June, 29th. The company reported ($0.21) earnings per share for the quarter, hitting analysts' consensus estimates of ($0.21). The firm had revenue of $0.13 million for the quarter. PetVivo had a negative net margin of 1,016.64% and a negative trailing twelve-month return on equity of 1,319.59%.

How do I buy shares of PetVivo?

Shares of PETV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:PETV) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners
Elon to Transform U.S. Economy?
Porter & Company
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!
Priority Gold
"The Biggest Drug Ever" Is Coming
Behind the Markets
Most important medical advance in 100 years
The Oxford Club
Does this make you sick?
Allegiance Gold
The Overlooked Retirement Asset You Probably Don’t Own
Crypto 101 Media
CEO of Biggest AI Chipmaker Just Dropped a Bombshell…
Banyan Hill Publishing
This Apple-like Innovator is Revolutionizing Healthcare
Wall Street Star